# AET05 variant 1 is produced correctly

    Code
      res
    Output
                                                 Placebo          Xanomeline High Dose   Xanomeline Low Dose
                                                 (N=86)                  (N=84)                (N=84)       
      ——————————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                 -0.2                    -2.0                  -2.9        
      Number of adverse events observed            21                      32                    37         
      AE rate per 100 patient-years             -9961.36                -1603.29              -1259.48      
      95% CI                              (-14221.83, -5700.90)   (-2158.79, -1047.79)   (-1665.31, -853.66)

# AET05 variant 2 is produced correctly

    Code
      res
    Output
                                                 Placebo          Xanomeline High Dose   Xanomeline Low Dose
                                                 (N=86)                  (N=84)                (N=84)       
      ——————————————————————————————————————————————————————————————————————————————————————————————————————
      Total patient-years at risk                 -0.2                    -2.0                  -2.9        
      Number of adverse events observed            21                      32                    37         
      AE rate per 100 patient-years             -9961.36                -1603.29              -1259.48      
      95% CI                              (-6166.24, -15227.00)   (-1096.65, -2263.37)   (-886.79, -1736.03)

